Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Diabetes monitoring | Image credit: abidika - stock.adobe.com
New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

April 23rd 2025

A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 diabetes—but not all obesity-related cancers show a link.

Rural health sign | Image credit: BJP7images - stock.adobe.com
FQHCs Show Low Engagement in Hypertension, Diabetes Trials

April 15th 2025

AI representation of housing stability | Image credit: GoldPumaze - stock.adobe.com
Housing Instability Linked to Worse Type 2 Diabetes Outcomes

April 14th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com
GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

April 9th 2025

AJMC
The Role of Advanced Technologies in Improving Diabetes Outcomes

April 7th 2025

More News

In Real-World Study, Toujeo Reduced Risks of Severe Hypoglycemia Compared With Older Insulins
February 15th 2018

In Real-World Study, Toujeo Reduced Risks of Severe Hypoglycemia Compared With Older Insulins

Mary Caffrey
The study used a claims database to examine records from patients who switched between long-acting insulins.
Congress Includes Language Protecting the Rights of Diabetes Patients in Budget Deal
February 14th 2018

Congress Includes Language Protecting the Rights of Diabetes Patients in Budget Deal

Kaitlynn Ely
Language in the new government budget ensures effective changes to CMS' Competitive Bidding Program for diabetes testing supplies that will benefit patients with diabetes.
Gallup-Sharecare: Sense of Well-Being Sees Biggest Drop Since Great Recession
February 13th 2018

Gallup-Sharecare: Sense of Well-Being Sees Biggest Drop Since Great Recession

Mary Caffrey
Such a large drop in Americans' sense of well-being in their daily lives in a time of economic good fortune is unprecedented, index organizers say.
Site Logo
February 13th 2018

After a Year, Low-Carb Diet Helps Many Patients Reverse Type 2 Diabetes, Lose Weight, and Stop Insulin

Mary Caffrey
Of the 262 patients with type 2 diabetes in the intervention, 83% stuck with it through the first year, despite significant requirements.
Study Finds Exposure to Areas With High Overweight/Obesity Rates Affects BMI
February 12th 2018

Study Finds Exposure to Areas With High Overweight/Obesity Rates Affects BMI

Kaitlynn Ely
An individual’s body mass index (BMI) can increase when exposed to counties with a higher prevalence of obesity, according to a study published in JAMA Pediatrics.
Medicare Continues to Fight CGM Coverage in Court, and Told to Pay
February 3rd 2018

Medicare Continues to Fight CGM Coverage in Court, and Told to Pay

Mary Caffrey
Despite an official policy since early 2017 that calls for Medicare to cover CGM for certain beneficiaries with diabetes, an attorney who won a landmark case prior to the policy change reports that beneficiaries are still being denied coverage.
Podcast: This Week in Managed Care—State of the Union and Other Health News
February 3rd 2018

Podcast: This Week in Managed Care—State of the Union and Other Health News

Laura Joszt, MA
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: February 2, 2018
February 2nd 2018

This Week in Managed Care: February 2, 2018

This week, the top managed care news included President Donald Trump vowing to lower drug prices during his State of the Union address; 3 corporate giants joined forces on healthcare; and CAR T-cell therapy was named the cancer advance of the year.
Prime Therapeutics, Boehringer-Ingelheim Reach Outcomes-Based Contract for Jardiance
January 30th 2018

Prime Therapeutics, Boehringer-Ingelheim Reach Outcomes-Based Contract for Jardiance

Mary Caffrey
Empagliflozin (Jardiance) and another SGLT2 inhibitor, canagliflozin (Invokana) have been competing aggressively; both have clinical trial results showing cardiovascular benefits.
Site Logo
January 29th 2018

Omada Health Diabetes Prevention Trial to Track Healthcare Utilization

Mary Caffrey
Officials at Omada Health said the PREDICTS trial was planned long before CMS decided not to include virtual providers in this spring's launch of the Medicare Diabetes Prevention Program. But a spokesperson said the company hopes the growing body of evidence in support of virtual programs will "assuage any concerns."
Solera Health, WellDoc Partnership a "Natural Evolution" That Will Address Diabetes Prevention, Management
January 19th 2018

Solera Health, WellDoc Partnership a "Natural Evolution" That Will Address Diabetes Prevention, Management

Mary Caffrey
The pairing will give employers and health plans "holistic" solutions for chronic disease management, according to CEOs of the companies.
Site Logo
January 17th 2018

Bridging the Digital Divide: Mobile Access to Personal Health Records Among Patients With Diabetes

Ilana Graetz, PhD Jie Huang, PhD Richard J. Brand, PhD John Hsu, MD, MBA, MSCE Cyrus K. Yamin, MD Mary E. Reed, DrPH
Racial/ethnic minorities and patients living in poorer neighborhoods were more likely to access their personal health record exclusively with a mobile device.
Podcast: This Week in Managed Care—New Voluntary Payment Model and Other Health News
January 13th 2018

Podcast: This Week in Managed Care—New Voluntary Payment Model and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
After Long Wait, Omnipod Achieves Coverage Through Medicare Part D
January 13th 2018

After Long Wait, Omnipod Achieves Coverage Through Medicare Part D

Mary Caffrey
This Week in Managed Care: January 12, 2018
January 12th 2018

This Week in Managed Care: January 12, 2018

This week, the top managed care stories included CMS unveiling a new voluntary bundled payment model; coverage from the JP Morgan Healthcare Conference, including immunotherapy's impact on HIV treatment and biosimilars; and news that 2 key diabetes devices will be covered by Medicare.
Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds
January 12th 2018

Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds

Mary Caffrey
The same mechanisms that cause those with long-term HIV infection to suffer higher rates of heart attacks or strokes put children born with disease at early risk of cardiovascular disease, according to a new study.
5 Things From the 36th Annual JP Morgan Healthcare Conference
January 12th 2018

5 Things From the 36th Annual JP Morgan Healthcare Conference

Kelly Davio
This week, the investors and analysts turned their attention to presentations by business leaders at the 36th Annual JP Morgan Healthcare Conference, held in San Francisco, California. Executives from the pharmaceutical and healthcare worlds showcased their products, pipelines, and visions for the future.
Study Shows the Impact Synchronization Programs Have on Medication Adherence
January 10th 2018

Study Shows the Impact Synchronization Programs Have on Medication Adherence

Kaitlynn Ely
Older adults who are prescribed many medications that require frequent trips to the pharmacy are more likely to not refill their prescriptions on time, but patients who participate in medication synchronization programs have improved adherence to cardiovascular medications, according to a study published in Health Affairs.
A Leader in Diabetes Prevention Gets Ready to Help Medicare Reach Seniors Everywhere
January 10th 2018

A Leader in Diabetes Prevention Gets Ready to Help Medicare Reach Seniors Everywhere

Mary Caffrey
Brenda Schmidt, CEO of Solera Health, discusses the historic launch of the Medicare Diabetes Prevention Program scheduled for this April and how her company is helping providers and other stakeholders get ready.
The Importance of Adding the Diabetes Prevention Program to Medicare
January 10th 2018

The Importance of Adding the Diabetes Prevention Program to Medicare

Brenda Schmidt is CEO of Solera Health, an integrator that serves as the “back office” for both community-based and digital providers of the Diabetes Prevention Program (DPP), an evidence-based program that has been shown to reduce incidence of people with prediabetes progressing to type 2 diabetes. In April, Medicare will take the historic step of launching the DPP for beneficiaries, and Solera has been at the forefront of helping providers navigate the policy and technical hurdles to serve clients who will take part in the DPP.
Site Logo
January 9th 2018

Medical World News: Regulatory Updates

AJMC Staff
Abbott's Freestyle Libre CGM Gains Medicare Coverage
January 6th 2018

Abbott's Freestyle Libre CGM Gains Medicare Coverage

Mary Caffrey
The factory-calibrated continuous glucose monitoring (CGM) system is being touted as less expensive, and a spokeswoman said it will not require bundling with a meter, which is required for a competitor.
Dexcom Works to Bring CGM to the Medicare Population, and More
January 4th 2018

Dexcom Works to Bring CGM to the Medicare Population, and More

Mary Caffrey
Dexcom Executive Vice President and Chief Commercial Officer RIck Doubleday visited The American Journal of Managed Care® to discuss Medicare reimbursement for the Dexcom G5 and a new partnership with Fitbit.
Rick Doubleday Discusses Bringing the Dexcom CGM to Medicare Beneficiaries
January 4th 2018

Rick Doubleday Discusses Bringing the Dexcom CGM to Medicare Beneficiaries

Rick Doubleday is the executive vice president, and chief commercial officer at Dexcom. He is responsible for the sales, marketing and customer service functions. Previously, Doubleday led all sales and marketing functions for the company, driving the acceleration of worldwide awareness and adoption of Dexcom continuous glucose monitoring (CGM). Doubleday visited The American Journal of Managed Care® this fall to discuss bringing the Dexcom G5 to Medicare beneficiaries.
Site Logo
January 3rd 2018

Medical World News: Business Updates

AJMC Staff
Site Logo
December 29th 2017

Cardiovascular Outcomes Are the Focus of Evidence-Based Diabetes ManagementTM, a Publication of The American Journal of Managed Care&reg

Cost considerations and potential for prevention covered in current issue of Evidence-Based Diabetes ManagementTM.
FDA Approves First Shock Wave Device to Treat Diabetic Foot Ulcers
December 29th 2017

FDA Approves First Shock Wave Device to Treat Diabetic Foot Ulcers

Allison Inserro
The FDA has approved the sale of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.
Lifestyle Articles Top 2017 Favorites in Evidence-Based Diabetes ManagementTM
December 28th 2017

Lifestyle Articles Top 2017 Favorites in Evidence-Based Diabetes ManagementTM

Mary Caffrey
Adapting payment models to reward outcomes is key to making lifestyle change fit into a managed care framework, several articles find.
Site Logo
December 26th 2017

Perspectives of a Lipidologist: LDL Cholesterol Testing, PCSK9 Inhibitors

Mary Caffrey
Podcast: This Week in Managed Care—Individual Mandate Eliminated and Other Health News
December 23rd 2017

Podcast: This Week in Managed Care—Individual Mandate Eliminated and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
<1
...
282930313233343536
...
98>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo